Skip to content

Back to the beginning * the Amylon study: Serum amylase, urinary amylase and serum lipase for diagnosing acute pancreatitis

Back to the beginning * the Amylon study: Serum amylase, urinary amylase and serum lipase for diagnosing acute pancreatitis - the Amylon study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44831
Enrollment
180
Registered
2014-04-16
Start date
2014-08-22
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreasontstekingsaandoeningen acute inflammation of the pancreas Acute pancreatitis

Interventions

None listed

Sponsors

Medisch Centrum Haaglanden
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - hospitalized patients with acute onset of persistent, severe, epigastric pain - aged *18 years - able to provide written informed consent

Exclusion criteria

Exclusion criteria: complaints starting more than 7 days before admission chronic kidney disease (MDRD

Design outcomes

Primary

MeasureTime frame
The diagnostic accuracy (AUC/ROC) of serum amylase, serum lipase and urinary amylase for acute pancreatitis per day after onset of symptoms until day 5 and on day 7.

Secondary

MeasureTime frame
- difference in diagnostic accuracy (AUC/ROC) after subgroup analyses: different etiology of acute pancreatitis (f.e. alcohol induced, hyperlipidemia induced or biliary acute pancreatitis), and mild versus severe pancreatitis - difference in diagnostic accuracy (AUC/ROC) in urinary amylase versus amylase creatinine clearance ratio - difference in diagnostic accuracy (AUC/ROC) in one solitary pancreatic enzyme versus a combination of enzymes

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)